The ATTRACT Trial, primarily sponsored by the National Heart Lung and Blood Institute (NHLBI) will determine if the use of new clot-busting treatments for patients with large blood clots of the leg (deep vein thrombosis or DVT) prevents long-term disability. Please visit the ATTRACT Trial Web site at www.attract.wustl.edu or call 866.974.CLOT (2568) for more information.
Claudication: Exercise Versus Endoluminal Revascularization (CLEVER): The National Heart, Lung, and Blood Institute (NHLBI) is sponsoring a trial for patients with cardiovascular diseases, peripheral vascular diseases, or atherosclerosis to compare the effectiveness of aortic stent surgery versus exercise therapy.
The CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) study is a NIH funded study to determine the best treatment for patients who have high blood pressure and blockage of the renal artery that supplies blood to the kidney.
The University of Virginia is currently conducting several cardiology/vascular trials. Click here for details.